Minggen Yang
Zhangzhou, 363000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Low-dose abiraterone plus Olaparib as a late-line treatment for mCRPC patients without BRCA1/2 mutations: a multicenter retrospective pilot study.
Journal: Scientific reports
Published: February 11, 2024
Knockdown of growth differentiation factor-15 restrains prostate cancer through regulating MAPK/ERK signaling pathway.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: December 22, 2023
Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer.
Journal: Frontiers in pharmacology
Published: August 29, 2023
Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia.
Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia.
Journal: International neurourology journal
Published: January 08, 2021
Macrophages affect immune inflammation and proliferation in benign prostatic hyperplasia via androgen receptor and CD40/CD40L signaling pathway.
Journal: Tissue & cell
Published: September 11, 2019
Upregulation of GRIM-19 augments the sensitivity of prostate cancer cells to docetaxel by targeting Rad23b.
Journal: Clinical and experimental pharmacology & physiology
Published: June 24, 2019
Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19.
Journal: Gene
Published: August 29, 2018
ImmunoCyt™ and cytology for diagnosis of bladder carcinoma: a meta analysis.
Journal: Chinese medical journal
Published: February 19, 2014
Prophylatic antibiotic use in percutaneous nephrolithotomy: a meta-analysis
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: January 18, 2014
Corticoid combined with an antibiotic for chronic nonbacterial prostatitis
Journal: Zhonghua nan ke xue = National journal of andrology
Published: May 21, 2009
Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension
Journal: Zhonghua nan ke xue = National journal of andrology
Published: October 13, 2007
Showing 1-11 of 11
Last Updated: 09/26/2026